John D. Nash

747 total citations
20 papers, 595 citations indexed

About

John D. Nash is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Molecular Biology. According to data from OpenAlex, John D. Nash has authored 20 papers receiving a total of 595 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Reproductive Medicine, 5 papers in Obstetrics and Gynecology and 4 papers in Molecular Biology. Recurrent topics in John D. Nash's work include Ovarian cancer diagnosis and treatment (6 papers), Endometrial and Cervical Cancer Treatments (4 papers) and Cervical Cancer and HPV Research (3 papers). John D. Nash is often cited by papers focused on Ovarian cancer diagnosis and treatment (6 papers), Endometrial and Cervical Cancer Treatments (4 papers) and Cervical Cancer and HPV Research (3 papers). John D. Nash collaborates with scholars based in United States and Canada. John D. Nash's co-authors include Michael Teneriello, R. Ilona Linnoila, M. J. Birrer, Masahito Ebina, Michael D. Henry, David J. Carey, Virginia Mazack, Radhika Gogoi, Robert F. Ozols and John F. Smyth and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Radiology.

In The Last Decade

John D. Nash

19 papers receiving 581 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John D. Nash United States	12	254	177	162	109	84	20	595
Rudi Henriksen Sweden	9	247 1.0×	276 1.6×	223 1.4×	17 0.2×	106 1.3×	15	643
Yasunori Hashiguchi Japan	14	196 0.8×	236 1.3×	229 1.4×	18 0.2×	80 1.0×	37	549
Maxine L. Crook Australia	17	199 0.8×	211 1.2×	136 0.8×	28 0.3×	66 0.8×	35	613
Charles R. Boice United States	10	458 1.8×	191 1.1×	137 0.8×	20 0.2×	120 1.4×	12	648
Peter Schlosshauer United States	12	209 0.8×	270 1.5×	110 0.7×	20 0.2×	53 0.6×	20	568
Ivana Rizzuto United Kingdom	10	173 0.7×	141 0.8×	150 0.9×	20 0.2×	48 0.6×	24	457
Alessandro Bovicelli Italy	18	241 0.9×	165 0.9×	221 1.4×	19 0.2×	79 0.9×	38	749
Tjoung‐Won Park Germany	13	208 0.8×	222 1.3×	168 1.0×	12 0.1×	110 1.3×	21	719
Gaiko Ueda Japan	16	192 0.8×	145 0.8×	122 0.8×	29 0.3×	18 0.2×	53	607
Alfonso C. Almendral Switzerland	8	66 0.3×	126 0.7×	109 0.7×	24 0.2×	181 2.2×	15	446

Countries citing papers authored by John D. Nash

Since Specialization

Citations

This map shows the geographic impact of John D. Nash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John D. Nash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John D. Nash more than expected).

Fields of papers citing papers by John D. Nash

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John D. Nash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John D. Nash. The network helps show where John D. Nash may publish in the future.

Co-authorship network of co-authors of John D. Nash

This figure shows the co-authorship network connecting the top 25 collaborators of John D. Nash. A scholar is included among the top collaborators of John D. Nash based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John D. Nash. John D. Nash is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nash, John D., et al.. (2017). Time is money: Does IV Tylenol decrease time to discharge in patients undergoing robotic surgery for endometrial cancer?. Gynecologic Oncology. 145. 150–151.

Dasari, Venkata Ramesh, Virginia Mazack, Wen Feng, et al.. (2017). Verteporfin exhibits YAP-independent anti-proliferative and cytotoxic effects in endometrial cancer cells. Oncotarget. 8(17). 28628–28640. 87 indexed citations

Tsujiura, Masahiro, Virginia Mazack, Marius Sudol, et al.. (2014). Yes-Associated Protein (YAP) Modulates Oncogenic Features and Radiation Sensitivity in Endometrial Cancer. PLoS ONE. 9(6). e100974–e100974. 43 indexed citations

Tsujiura, Masahiro, Virginia Mazack, Marius Sudol, et al.. (2014). Yes-associated protein (YAP) functions as a proto-oncogene and promotes radiation resistance in endometrial cancer. Gynecologic Oncology. 133. 107–107. 1 indexed citations

Liu, Bei, et al.. (2010). Ovarian cancer immunotherapy: opportunities, progresses and challenges. Journal of Hematology & Oncology. 3(1). 49 indexed citations

Nash, John D., et al.. (2005). An autologous tumor-derived heat shock protein vaccine for high risk ovarian cancer. Journal of Clinical Oncology. 23(16_suppl). 9592–9592. 5 indexed citations

Elkas, John C., et al.. (1997). Evaluating the Endometrium in Women on Tamoxifen. Menopause The Journal of The North American Menopause Society. 4(1). 6???9–6???9. 3 indexed citations

Taylor, Robert R., R. Ilona Linnoila, Michael Teneriello, et al.. (1995). Abnormal Expression of the Retinoblastoma Gene in Ovarian Neoplasms and Correlation to P53 and K-ras Mutations. Gynecologic Oncology. 58(3). 307–311. 15 indexed citations

Teneriello, Michael, et al.. (1994). The molecular genetics of gyn malignancies.. PubMed. 8(10). 63–70, 73; discussion 73, 78. 2 indexed citations

10.

Germain, Mathieu, et al.. (1994). A comparison of the three most common Papanicolaou smear collection techniques.. PubMed. 84(2). 168–73. 26 indexed citations

11.

Teneriello, Michael, Masahito Ebina, R. Ilona Linnoila, et al.. (1993). p53 and Ki-ras gene mutations in epithelial ovarian neoplasms.. PubMed. 53(13). 3103–8. 185 indexed citations

12.

Remmenga, Steven W., et al.. (1992). Radical vulvectomy with partial rectal resection and temporary colostomy as primary therapy for selected patients with vulvar carcinoma. International Journal of Gynecology & Obstetrics. 38(2). 148–149. 8 indexed citations

13.

Barnhill, Danny, et al.. (1991). Intestinal surgery performed on gynecologic cancer patients. Gynecologic Oncology. 40(1). 38–41. 12 indexed citations

14.

Nash, John D., et al.. (1991). Patients as “Subjects” or “Objects” in Residency Education?. The Journal of Clinical Ethics. 2(1). 35–41. 13 indexed citations

15.

Barnhill, Danny, et al.. (1990). Osseous metaplasia in ovarian papillary serous cystadenocarcinoma. Gynecologic Oncology. 39(2). 228–231. 18 indexed citations

16.

Nash, John D., Robert F. Ozols, John F. Smyth, & Thomas C. Hamilton. (1989). Estrogen and Anti-Estrogen Effects on the Growth of Human Epithelial Ovarian Cancer In Vitro. American Journal of Obstetrics and Gynecology. 73(6). 1009–1016. 74 indexed citations

17.

Nash, John D., et al.. (1989). Estrogenic regulation and growth factor expression in human ovarian cancer (HOC) in vitro. Gynecologic Oncology. 32(1). 127–127. 3 indexed citations

18.

Nash, John D., Thomas W. Burke, Joan E. Woodward, et al.. (1988). Diagnosis of recurrent gynecologic malignancy with fine-needle aspiration cytology.. PubMed. 71(3 Pt 1). 333–7. 11 indexed citations

19.

Burke, Thomas W., Paul B. Heller, William J. Hoskins, et al.. (1987). Evaluation of the scalene lymph nodes in primary and recurrent cervical carcinoma. Gynecologic Oncology. 28(3). 312–317. 7 indexed citations

20.

Sachs, Larry, et al.. (1982). Prenatal detection of umbilical cord allantoic cyst.. Radiology. 145(2). 445–446. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact